Miramar, FL, United States of America

Saul A Rios

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Saul A. Rios

Introduction

Saul A. Rios is a notable inventor based in Miramar, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. With a total of 2 patents to his name, Rios has demonstrated a commitment to advancing medical technology.

Latest Patents

Rios's latest patents focus on a controlled release pharmaceutical composition. This innovative dosage form is designed to provide sustained or prolonged release of medication. The formulation includes a hard shell capsule and consists of several key components: (a) a water insoluble medicant, (b) a high melting fatty ester, (c) a low viscosity oil, (d) a cellulosic polymer, and (e) a non-ionic surfactant. This combination aims to enhance the effectiveness and efficiency of pharmaceutical treatments.

Career Highlights

Saul A. Rios is currently associated with Kos Pharmaceuticals, Incorporated. His work at this company has allowed him to focus on developing advanced pharmaceutical solutions that address various medical needs. His expertise in controlled release formulations has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Rios has collaborated with several professionals in his field, including Jose Gutierrez-Rocca and Josephine Dunne. These collaborations have contributed to the successful development of his innovative patents and have fostered a collaborative environment for research and development.

Conclusion

Saul A. Rios is a prominent inventor whose work in controlled release pharmaceutical compositions has the potential to significantly impact the medical field. His contributions through patents and collaborations highlight his dedication to innovation in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…